Navigation Links
Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
Date:1/29/2008

Athletes Using Surgex(TM) can be Assured of No Banned Substances

BASKING RIDGE, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), announced today that Surgex(TM) (http://www.surgexsports.com) has been tested and certified into the Banned Substance Control Group's (BSCG) certification program. This is the only certification program in the US that uses a World Anti Doping Agency accredited laboratory to detect for dangerous banned substances in nutritional supplements. Each batch of Millennium's line of Surgex(TM) products are now tested and certified not to contain substances such as hormones, steroids, stimulants, diuretics, etc that are banned for Professional, Collegiate and Olympic sports. The BSCG certification in addition to the Surgex'(TM) clinical trials should provide the product a competitive advantage upon commercialization into the billion dollar sports nutritional supplement marketplace.

"The athlete can now be assured that our Surgex(TM) line of products can be safely consumed as each batch is tested for a list of substances that are banned by organizations such as the International Olympic Committee (IOC), the World Anti-Doping Agency (WADA), the United States Anti-Doping Agency (USADA), the National Collegiate Athletic Association (NCAA), the National Football League (NFL), and many other professional and amateur sports leagues." states Carl Germano, RD, CNS, CDN, clinical nutritionist and VP of Research & product Development for Millennium Biotechnologies.

With over 5 years in the medical market as a nutritional adjunct to medical care for immuno-compromised conditions and several successful studies including 2 double blind, placebo controlled trials in Division 1 athletes, the Surgex(TM) line of products is breaking new ground for credibility and pro
'/>"/>

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
4. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
7. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VR...nandDisclosureStatementtoday,November24,2009,witht...are.AhearingtoconsiderapprovaloftheDisclosureState...earingontheconfirmationofthePlanscheduledforJanuar...aimsinfull.ThePlanisexpected,ifapproved,toallowhol...
(Date:11/24/2009)...ccumetrics,Inc.,aprivately-helddeveloperandmarkete...o-usediagnosticsystemformeasuringanindividual,sres...andaspirin),announcedtodaythatTimothyI.Still,Presi...FinancialOfficerofAccumetrics,willbepresentingacor...eConferencebeingheldinNewYorkCityonDecember1-2,200...
(Date:11/24/2009)...mbitBiosciencesCorporationannouncedtodaythattherew...condgenerationFLT3inhibitor,inAMLatthe51stAmerican...Orleans,LA,December5-8,2009.Anoralpresentationwill...rapysafetystudyinadultswithacutemyeloidleukemia(AM...luatingtheeffectofAC220monotherapyandincombination...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3New ANTEK MultiTek 28TM 29 by PAC Provides Fast All in One Testing for Sulfur Nitrogen Halides 5203 1New ANTEK MultiTek 28TM 29 by PAC Provides Fast All in One Testing for Sulfur Nitrogen Halides 5203 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 1Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 3National report shines light on lupus 50 year treatment drought 10254 1National report shines light on lupus 50 year treatment drought 10254 2National report shines light on lupus 50 year treatment drought 10254 3
...ITA SPRINGS, Fla., Jan. 30 Tigris Pharmaceuticals...has initiated a,multi-center, Phase I, ascending d...64) for the treatment of cancer. The first patient...ing., The primary objectives of the study are to ...imum tolerated dose (MTD) of AFP-464 in patients w...
...ERSET, N.J., Jan. 30 Alfacell Corporation,(Nasdaq...s (patient deaths),have occurred in the Phase IIIb... the treatment of patients with unresectable malig...e IIIb clinical trial was,closed on Sept. 30, 2007...al., In accordance with the statistical plan for ...
Other Medicine Technology:Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 3Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2
(Date:11/25/2009)...t fly study may lead to new drugs for people, rese...thDay News) -- Sphingadienes, natural lipid molecu... treatments for colon cancer, California researche... but the study authors pointed out that they could...against colon cancer. , In the study, Dr. Julie...
(Date:11/25/2009)...ify role mitochondrial function plays in insulin p...Day News) -- Mitochondrial damage causes people wi..., a finding that could lead to new treatments, U.S...y for cellular activity. , The researchers foun...ncreas can,t respond to circulating insulin, it tr...
(Date:11/25/2009)... Citing support for recent enforcement act... National Association of Chain Drug Stores (NACDS)...ation (FDA). The letter expresses the Association...domestic and foreign, that are engaged in a patter...d dispensing of prescription medications. , ...
(Date:11/25/2009)...iz.,Nov.25 /PRNewswire-FirstCall/-- TheProvidenc...atitsLogistiCaresubsidiary,thenation,slargestcoord...asreceivednoticeofawardfromtheStateofFloridaCommis...caidnon-emergencytransportationservicestobothMiami...h$14millioninrevenueovertheinitial18monthterm,issu...
(Date:11/25/2009)...N,Nov.25/PRNewswire-USNewswire/--/EINNews/EINNews,...ication,introducesitsnewesthealth-relatedpublicati...y( http://h1n1.einnews.com ). ,, H1N1NewsTodayg...mgovernments,newsoutletsandresearchcenterstheworld...newsontheglobaloutbreakwithreportsfromeverystatean...
Breaking Medicine News(10 mins):Health News:Natural Soy Component May Help Treat Colon Cancer 2Health News:NACDS Supports FDA Enforcement Against Rogue Internet Pharmacy Websites 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2
...ncing has become a,very popular way to pay for hig...t long after you have had your "nip and tuck", you... looking for ways to get out of debt, and at the s...g with his patients to help them be financially re...
...ire/ -- As online physician panels gain populari...es that conduct web-based surveys, research shows ...dents in these surveys are indeed genuine physicia...ying respondents. It can also be costly for the st...
...rgy Innovation and Job Creation , , HOUSTON, Jan...in the Houston, Texas region, will serve as the le...collaboration and as an accelerator for start-up c...ergy innovation -- represents a national solution ...
...s Events announced,today that Anthem Blue Cross an... sponsor for three race events in northeastern Wi...sha, Race the Lake bicycle event in Fond du Lac,an...event expositions in each city and will have a str...
...s have been inactive in the state where they are l...t require them to undergo competency tests or retr...icine. , Because of the lack of regulation, patie...the American Board of Pediatrics. , "Studies hav...
...aph for Registered Nurses and Nurse Practitioners ...l years, the incidence and mortality rates of Clo... dramatically. CDI is a serious condition, particu...ive that healthcare professionals be aware of the ...
Other Medicine News:Health News:Lay Away Plan for Cosmetic Surgery 2Health News:Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan 2Health News:Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan 3Health News:Nano World Headquarters Positioned to Boost U.S. Economy 2Health News:Nano World Headquarters Positioned to Boost U.S. Economy 3Health News:Nano World Headquarters Positioned to Boost U.S. Economy 4Health News:Anthem Blue Cross and Blue Shield to Serve as Title Sponsor for Three Race Events in Northeastern Wisconsin 2Health News:Anthem Blue Cross and Blue Shield to Serve as Title Sponsor for Three Race Events in Northeastern Wisconsin 3Health News:Most inactive physicians retain licenses, return to practice without competency review 2Health News:Clostridium difficile Infection: Best Strategies for Care of Older Adults 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: